Summit stock soars as lung cancer drug beats Merck’s Keytruda in late-stage trial
Source: Seekingalpha
Summit stock soars as lung cancer drug beats Merck’s Keytruda in late-stage trial
1 Min Read
Previous ArticleTerns stock jumps as weight loss drug succeeds in early trial
Next Article Eli Lilly taps veteran Lucas Montarce as new CFO